Inactive Instrument

Acarix AB (publ) Stock Nasdaq Stockholm

Equities

SE0009268717

Advanced Medical Equipment & Technology

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 86.9M 8.06M 10.99M Sales 2025 * 191M 17.74M 24.19M Capitalization 242M 22.44M 30.61M
Net income 2024 * -24M -2.23M -3.04M Net income 2025 * 58M 5.38M 7.33M EV / Sales 2024 * 2.74 x
Net cash position 2024 * 4M 371K 506K Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.27 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.07%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Founder 60 06-12-31
Director of Finance/CFO 60 15-12-31
Chief Tech/Sci/R&D Officer 47 21-12-31
Members of the board TitleAgeSince
Chairman 51 21-05-10
Director/Board Member 64 13-12-31
Director/Board Member 70 21-05-10
More insiders
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW